Celularity Inc.

Healthcare · Biotechnology · United States

Last price 0.8001 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 25.96M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Celularity Inc., a cellular and regenerative medicine company, focuses on addressing aging-related disease using novel therapies. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It develops off-the-shelf placental-derived allogeneic cell therapy product candidates, including mesenchymal-like adherent stromal cells for diabetic foot ulcer and Crohn’s disease. Its therapeutic programs include PDA-001 for the treatment of autoimmune (Crohn’s) and degenerative disease; and PDA-002 for treating multip...